Similar articles for PMID: 27103025

Year	Number of Results
1997	1
1999	1
2000	2
2001	2
2002	1
2003	1
2004	2
2005	1
2006	6
2007	6
2008	7
2009	8
2010	8
2011	12
2012	10
2013	17
2014	16
2015	23
2016	33
2017	41
2018	35
2019	20
2020	28
2021	16
2022	20
2023	10
2024	0

1

18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.

Humbert O, Riedinger JM, Vrigneaud JM, Kanoun S, Dygai-Cochet I, Berriolo-Riedinger A, Toubeau M, Depardon E, Lassere M, Tisserand S, Fumoleau P, Brunotte F, Cochet A. Humbert O, et al. J Nucl Med. 2016 Nov;57(11):1707-1712. doi: 10.2967/jnumed.116.172759. Epub 2016 Apr 21. J Nucl Med. 2016. PMID: 27103025 Free article. Clinical Trial.

2

Breast Cancer Blood Flow and Metabolism on Dual-Acquisition ¹⁸F-FDG PET: Correlation with Tumor Phenotype and Neoadjuvant Chemotherapy Response.

Humbert O, Lasserre M, Bertaut A, Fumoleau P, Coutant C, Brunotte F, Cochet A. Humbert O, et al. J Nucl Med. 2018 Jul;59(7):1035-1041. doi: 10.2967/jnumed.117.203075. Epub 2018 Feb 9. J Nucl Med. 2018. PMID: 29439010 Free article. Clinical Trial.

3

¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.

Groheux D, Biard L, Giacchetti S, Teixeira L, Hindié E, Cuvier C, Vercellino L, Merlet P, de Roquancourt A, de Cremoux P, Resche-Rigon M, Espié M. Groheux D, et al. J Nucl Med. 2016 Apr;57(4):536-43. doi: 10.2967/jnumed.115.163907. Epub 2015 Dec 23. J Nucl Med. 2016. PMID: 26697967 Free article.

4

The Prognostic Impact of Early Change in 18F-FDG PET SUV After Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer.

Lee HW, Lee HM, Choi SE, Yoo H, Ahn SG, Lee MK, Jeong J, Jung WH. Lee HW, et al. J Nucl Med. 2016 Aug;57(8):1183-8. doi: 10.2967/jnumed.115.166322. Epub 2016 Mar 31. J Nucl Med. 2016. PMID: 27033896 Free article.

5

Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.

Groheux D, Hindié E, Giacchetti S, Hamy AS, Berger F, Merlet P, de Roquancourt A, de Cremoux P, Marty M, Hatt M, Espié M. Groheux D, et al. Eur J Cancer. 2014 Jul;50(11):1864-71. doi: 10.1016/j.ejca.2014.04.020. Epub 2014 May 16. Eur J Cancer. 2014. PMID: 24841218

6

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.

Groheux D, Biard L, Lehmann-Che J, Teixeira L, Bouhidel FA, Poirot B, Bertheau P, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, de Cremoux P. Groheux D, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4. Eur J Nucl Med Mol Imaging. 2018. PMID: 29616304

7

Complete Metabolic Response on Interim ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Chen S, Ibrahim NK, Yan Y, Wong ST, Wang H, Wong FC. Chen S, et al. Oncologist. 2017 May;22(5):526-534. doi: 10.1634/theoncologist.2016-0334. Epub 2017 Apr 4. Oncologist. 2017. PMID: 28377466 Free PMC article.

8

Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.

Ueda S, Yoshizawa N, Shigekawa T, Takeuchi H, Ogura H, Osaki A, Saeki T, Ueda Y, Yamane T, Kuji I, Sakahara H. Ueda S, et al. J Nucl Med. 2016 Aug;57(8):1189-95. doi: 10.2967/jnumed.115.167320. Epub 2016 Mar 3. J Nucl Med. 2016. PMID: 26940765 Free article.

9

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer.

Koolen BB, Pengel KE, Wesseling J, Vogel WV, Vrancken Peeters MJ, Vincent AD, Gilhuijs KG, Rodenhuis S, Rutgers EJ, Valdés Olmos RA. Koolen BB, et al. Breast. 2013 Oct;22(5):691-7. doi: 10.1016/j.breast.2012.12.020. Epub 2013 Feb 12. Breast. 2013. PMID: 23414930

10

Additional value of ¹⁸F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

van Ramshorst MS, Teixeira SC, Koolen BB, Pengel KE, Gilhuijs KG, Wesseling J, Rodenhuis S, Valdés Olmos RA, Rutgers EJ, Vogel WV, Sonke GS, Vrancken Peeters MT. van Ramshorst MS, et al. Cancer Imaging. 2017 May 25;17(1):15. doi: 10.1186/s40644-017-0117-5. Cancer Imaging. 2017. PMID: 28545563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

281 results

Results by year